Pseudovirus neutralization VSV-based assay
VIRUS
To evaluate the neutralizing effect of the sera from participants treated with PTX-COVID19-B, a pseudotyped virus neutralization assay developed and validated at Nexelis, Canada to quantify the titer of neutralizing antibody against SARS-CoV-2